Rxsight, Inc. · NASDAQ:RXST
Wilterding Mark sold 7,765 Rxsight, Inc. shares (Form 4)
Traded Aug 31 to Sep 2, 2026 · Filed Sep 2, 2026
From Aug 31 to Sep 2, 2026, Wilterding Mark (Chief Financial Officer) sold 7,765 Rxsight, Inc. shares at US$6.96 for US$54,044, leaving 25,049 shares. Filed Sep 2, 2026 (Form 4).
- Sold
- 7,765 shares
- Price
- US$6.96
- Value
- US$54,044
- Holding after
- 25,049 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | Option exercise | 20,441 | 32,814 | Direct | |
| Sep 2, 2026 | Common Stock | Sale | 7,765 | US$6.96 | 25,049 | Direct |